Abbott’s Freestyle Libre System Receives Health Canada Authorization Under Interim Order for Hospitalized Patients During COVID-19

Abbott’s Freestyle Libre System Receives Health Canada Authorization Under Interim Order for Hospitalized Patients During COVID-19

Shots:Shots:

  • Health Canada has authorized the use of Abbott’s FreeStyle Libre system in the hospital amid COVID-19. The authorization will allow HCPs to remotely monitor patients’ glucose status to minimize exposure during COVID-19 and preserve the use of PPE
  • Additionally, Abbott will donate ~3,000 FreeStyle Libre sensors to provide immediate access to the hospital. The studies demonstrated that users of the FreeStyle Libre system have improved glucose control, decreased time in hyperglycemia and hypoglycemia, reduced hospitalizations and HbA1C levels
  • FreeStyle Libre sensor is worn on the back of the upper arm, glucose readings are measured every min. and the user can get current glucose measurements mean while physicians will receive glucose data and actionable information remotely via LibreView, cloud-based diabetes management system available at no cost to HCPS and users

Click here ­to­ read full press release/ article | Ref: Abbott | Image: Forbes